Revance Therapeutics Funding & Investors
Revance Therapeutics, Inc. produces biopharmaceutical products. The Company develops drug delivery and treatments for dermatology and aesthetic medicine. Revance Therapeutics serves patients and doctors throughout the United States.
revance.comTotal Amount Raised: $1,579,526,016
Revance Therapeutics Funding Rounds
Series E
$33,000,000
Series E Investors
Delphi VenturesEssex WoodlandsNovaQuest Capital ManagementSeries D
$45,000,000
Series D Investors
CNF InvestmentsEssex CapitalVivo CapitalPac-LinkPalo Alto InvestorsEssex WoodlandsTechnology PartnersShepherd VenturesNovaQuest Capital ManagementSeries D
$25,620,000
Series D Investors
EDBIVivo CapitalPac-LinkPalo Alto InvestorsEssex WoodlandsTechnology PartnersShepherd VenturesBio*One CapitalPost Ipo Equity
$126,000,000
Post Ipo Equity
$131,300,000
Series Unknown
$10,000,000
Debt Financing
$8,000,000
Debt Financing Investors
Leader VenturesHorizon Technology FinanceSeries C
$43,200,000
Series C Investors
Medicis PharmaceuticalVivo CapitalPalo Alto InvestorsEssex WoodlandsTechnology PartnersShepherd VenturesSeries B
$13,000,000
Series B Investors
Vivo CapitalEssex WoodlandsTechnology PartnersSeries A
$1,806,000
Post Ipo Equity
$200,000,000
Post Ipo Debt
$300,000,000
Post Ipo Debt Investors
Athyrium Capital ManagementPost Ipo Debt
$250,000,000
Post Ipo Equity
$110,500,000
Post Ipo Equity
$115,000,000
Post Ipo Equity
$167,100,000
Post Ipo Equity Investors
Cowen Investment ManagementPost Ipo Equity
$200,000,000
Post Ipo Debt
$300,000,000
Post Ipo Debt Investors
Athyrium Capital ManagementPost Ipo Equity
$110,500,000
Post Ipo Equity
$167,100,000
Post Ipo Equity Investors
Cowen Investment ManagementPost Ipo Equity
$115,000,000
Post Ipo Debt
$250,000,000